Exercise may counteract side effects of prostate cancer hormone therapy
NCT ID NCT07680920
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This trial investigates whether a supervised program of aerobic and strength training can improve quality of life, heart function, and body composition in men with prostate cancer who are receiving androgen deprivation therapy (hormone therapy). The study involves 46 men aged 40 to 75 with stage I-III prostate cancer. Participants will be randomly assigned to either a 12-week supervised exercise group or a control group. Researchers will measure changes in quality of life, physical function, blood pressure, and body fat before and after the program.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
supervised combined aerobic and strength training
What this could lead to
If effective, supervised exercise could become a standard way to reduce side effects of hormone therapy for prostate cancer, improving daily life and heart health.
What could go wrong
This is a small, early-stage trial with only 46 participants, so results may not apply to all patients. Exercise may not significantly improve all measured outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER PATIENTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 177Lu-PSMA-617 & Darolutamide for Prostate Cance NCT07677566
- Genetic Testing Education for Prostate Cancer Su NCT07618520
- Enzalutamide Dose Study in Elderly Prostate Canc NCT07512076
- SBRT with Durvalumab for Prostate Cancer (NCT03795207)
- Prostate Cancer Radiotherapy Study (NCT07489729)
- RADVAN Trial: Radiotherapy for Node-Positive Pro NCT07477626